Comparison of in vitro effects of the pure antiandrogens OH-flutamide, casodex, and nilutamide on androgen-sensitive parameters

By Simard J.   Singh S.M.   Labrie F.  

Urology, Vol. 49, Iss. 4, 1997-04 ,pp. : 580-589

Elsevier

Access to resources Recommend Favorite

Mineralocorticoid Receptor Antagonist for Renal Protection

By Ma Terry King-Wing   Szeto Cheuk-Chun  

Renal Failure, Vol. 34, Iss. 6, 2012-07 ,pp. : 810-817

Informa Healthcare

Access to resources Recommend Favorite

Significance of the polyglutamine tract polymorphism in the androgen receptor

By Casella R.   Maduro M.R.   Lipshultz L.I.   Lamb D.J.  

Urology, Vol. 58, Iss. 5, 2001-11 ,pp. : 651-656

Elsevier

Access to resources Recommend Favorite

Different expression of androgen receptor coactivators in human prostate

By Fujimoto N.   Mizokami A.   Harada S.   Matsumoto T.  

Urology, Vol. 58, Iss. 2, 2001-08 ,pp. : 289-294

Elsevier

Access to resources Recommend Favorite

Effective long-term androgen suppression in men with prostate cancer using a hydrogel implant with the GnRH agonist histrelin

By Schlegel P.N.   Kuzma P.   Frick J.   Farkas A.   Gomahr A.   Spitz I.   Chertin B.   Mack D.   Jungwirth A.   King P.   Nash H.   Bardin C.W.   Moo-Young A.  

Urology, Vol. 58, Iss. 4, 2001-10 ,pp. : 578-582

Elsevier

Access to resources Recommend Favorite